Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: wondering

Is the company staking it's entire future on the T3 case?

Anybody read the risk section of the quarterly yet?

Is the reason for having an in person shareholder meeting, to ask shareholders for approval to sell the company?

Comments?

Speculation only.

Share
New Message
Please login to post a reply